Ultra-sensitive tests for early diagnosis of SARS-CoV-2 infection. Available at Lilium’s Rapid Testing Centers
Lilium’s Covid testing platform provides high accuracy with minimal false positives or false negatives.
Companies and institutions can deploy large-scale COVID tests at a fraction of the cost of testing centers with LILIUM’s automated SARS-CoV-2 virus detection and reporting.
LILIUM’S pioneering testing system secures workplaces and communities against expensive lockdowns by keeping businesses and organizations ahead of outbreaks.
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives while reducing risks associated with testing site transmission of the virus.
Lilium’s proprietary testing platform can test tens of thousands or hundreds of thousands of people on the same day prior to an event (e.g. for sports stadiums, festivals, cruises, large airports) or even entire cities.
Laboratory reporting of results can be delivered as quickly as an hour.
Our current COVID-testing paradigm relies on RT-PCR administered by human operators. This process generates a number of problems, including a shortage of highly trained operators, variations in accuracy based on human error, cross-contamination of test samples, and low sensitivity, which makes it difficult or impossible to detect virus carriers when they are at their most contagious.
LILIUM’s automated RT-PCR eliminates the need for human operators, mitigating the risk of cross-contamination and human error. What’s more, LILIUM’s large-scale testing capacity and high-sensitivity makes it possible to prevent the spread of the virus while carriers are pre-symptomatic without the need for lockdowns.
With its extreme accuracy and sensitivity combined with its massive scalability and fast turnaround of results, LILIUM could be deployed as a National Shield. All positive cases in a city or the entire country could be determined within days. This means only the positive cases would need to isolate while the rest of the population and the economy could get back to normal.
Rapid, accurate, large-scale COVID-testing has the capacity to halt community spread of the SARS-CoV-2 virus without lockdowns. By implementing the Lilium testing paradigm, we can protect our loved ones, communities, and workplaces starting today.
Current COVID tests are not able to detect and report the presence of the SARS-CoV-2 virus before a person becomes infectious (contagious). Even for the best available RT-PCR tests, it can take 24-72 hours to receive the test results which means that a carrier may have already passed peak-infectiousness (peak-contagiousness) before they even receive the results of the test.
LILIUM’s next-generation RT-PCR Covid testing platform has been designed with superior accuracy along with rapid turn-around of results. This makes it possible to prevent the spread of the virus by enabling carriers to become aware of their status very early so they can start isolating prior to becoming significantly infectious (contagious). This could eliminate the need for any lockdowns.
Lilium’s COVID testing platform has the capacity to halt community spread of the SARS-CoV-2 virus without lockdowns. By implementing Lilium’s testing technology, we can protect our loved ones, communities, and workplaces starting today.
With its extreme accuracy, sensitivity and specificity, combined with its massive scalability and fast turn-around of results, LILIUM could be deployed as a National Shield. All positive cases in a city or an entire country could be determined within days. This means only the positive cases would need to isolate for 2 weeks while the rest of the population and the economy could return back to normal.
Maximum use of green reagents and up to 90% less use of materials compared to other rapid tests, enables us to further reduce the costs of testing while simultaneously reducing the use of Earth’s valuable resources and waste
Do-it-your self COVID test kits are coming soon. Subscribe to be the first notified about availability